Protocol for transplantation of cells derived from human midbrain organoids into a Parkinson’s disease mouse model to restore motor function
Open Access
- 8 August 2024
- journal article
- research article
- Published by Elsevier in STAR Protocols
- Vol. 5 (3) , 103251
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson’s disease mouse modelHeliyon, 2024
- A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cellsCell Stem Cell, 2022
- Reversing a model of Parkinson’s disease with in situ converted nigral neuronsNature, 2020
- Generation of human brain region–specific organoids using a miniaturized spinning bioreactorNature Protocols, 2018
- Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV ExposureCell, 2016
- Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorderNature, 2015
- Modeling Hippocampal Neurogenesis Using Human Pluripotent Stem CellsStem Cell Reports, 2014